Biosource (NASDAQ:BIOIE)
Historical Stock Chart
From Oct 2019 to Oct 2024
BioSource International, Inc. (Nasdaq:BIOIE) today
announced that Nasdaq has informed the Company that effective on
Tuesday, July 5, 2005, BioSource common stock will once again trade
under its original trading symbol "BIOI."
The Company's stock has been trading under the amended symbol
"BIOIE" since May 27, 2005, subsequent to the Company receiving a
notice of delisting determination due to the delay in filing its
periodic report with the SEC on Form 10-Q for the quarter ended March
31, 2005. BioSource filed its 2005 first quarter 10-Q on June 28,
2005, and has received notification from the Nasdaq Office of General
Counsel, Listing Qualifications Hearings confirming compliance with
SEC filing requirements and all other requirements for continued
listing on the Nasdaq National Market. Accordingly, the Company's
delisting hearing has been canceled and the hearing file will be
closed.
About BioSource International, Inc.
BioSource International, Inc. is a broad-based life sciences
company focused on providing integrated solutions in the areas of
functional genomics, proteomics, and drug discovery through the
development, manufacturing, marketing, and distribution of unique,
biologically active reagent systems which facilitate, enable, and
accelerate pharmaceutical development and biomedical research. For
more information, please visit the Company's Web site at
www.biosource.com.
Statements included in this release that are not historical facts
may be considered forward-looking statements that are subject to a
variety of risks and uncertainties. In addition, readers are urged to
consider statements that include the terms "believes," "belief,"
"expects," "plans," "objectives," "anticipates," "intends," "targets,"
"projections," or the like to be uncertain and forward looking. For
these statements, we claim the safe harbor for "forward-looking
statements" within the meaning of the Private Securities Litigation
Reform Act of 1995. Factors that could cause actual results to differ
and vary materially from the forward-looking statements made herein
include, among others, our ability to expand our product offerings and
any transition to new products, product quality and availability, any
change in business conditions, changes in our sales strategy and
product development plans, competitive pricing pressures, continued
market acceptance of our products, name recognition of our products,
delays in the development of new technology, possible invalidity or
infringement issues related to intellectual property or proprietary
rights, changes in customer buying patterns, one-time events, the
effects of our previously announced process to evaluate strategic
alternatives, including a possible sale of the Company, and any
transaction we may enter into in connection with that process, and
other important factors disclosed previously and from time to time in
our filings with the Securities and Exchange Commission. These factors
should not be construed as exhaustive. We cannot always predict or
determine after the fact what factors would cause actual results to
differ materially from those indicated by the forward-looking
statements or other statements. We do not undertake any obligation to
publicly update or revise any forward-looking statements, whether as a
result of new information, future event, or otherwise.